Ismail Kola joins UCB, Inc. (UCBJF.PK) as Executive Vice President, UCB & President of UCB New Medicines(TM)
11/10/2009 11:17:38 AM
More...
|
UCB, Inc. (UCBJF.PK): New Data Presented From WELCOME Trial Show Positive Impact of CIMZIA(R) (certolizumab pegol) on Hospitalizations and Surgeries in Patients With Prior Infliximab Failure
10/26/2009 9:38:16 AM
More...
|
UCB, Inc. (UCBJF.PK): New Data Show CIMZIA(R) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohn's Patients
10/26/2009 9:07:33 AM
More...
|
UCB, Inc. (UCBJF.PK)'s Cimzia(R), Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid Arthritis
10/19/2009 9:12:11 AM
More...
|
UCB, Inc. (UCBJF.PK)'s Cimzia(R), The Only Pegylated Anti-TNF, Approved In Europe And Available In A Syringe Designed In Partnership With OXO Good Grips(R)
10/5/2009 10:34:32 AM
More...
|
UCB, Inc. (UCBJF.PK) And AstraZeneca AB Form Alliance For The Commercialization Of Cimzia(R) In Brazil
9/28/2009 10:56:42 AM
More...
|
UCB, Inc. (UCBJF.PK) Selects Cambridge Semantics for Enterprise-Wide Semantic Technology Solution
9/8/2009 8:52:22 AM
More...
|
UCB, Inc. (UCBJF.PK), Immunomedics, Inc. (IMMU) Lupus Treatment Shows Success; IMMU Shares Soar
8/27/2009 6:47:04 AM
More...
|
FDA Approves UCB, Inc. (UCBJF.PK), Sanofi-Aventis (France) (SASY.PA)'s XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria
8/24/2009 12:11:31 PM
More...
|
UCB, Inc. (UCBJF.PK) and Novartis Corporation (NVS) (JOBS) to Expand Cooperation in Germany
8/24/2009 6:37:39 AM
More...
|
|